AAAAAA

   
Results: 1-3 |
Results: 3
Detection of somatostatin receptor-positive tumours using the new Tc-99m-tricine-HYNIC-D-Phe(1)-Tyr(3)-octreotide: first results in patients and comparison with In-111-DTPA-D-Phe(1)-octreotide
Authors: Bangard, M Behe, M Guhlke, S Otte, R Bender, H Maecke, HR Biersack, HJ
Citation: M. Bangard et al., Detection of somatostatin receptor-positive tumours using the new Tc-99m-tricine-HYNIC-D-Phe(1)-Tyr(3)-octreotide: first results in patients and comparison with In-111-DTPA-D-Phe(1)-octreotide, EUR J NUCL, 27(6), 2000, pp. 628-637
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
Authors: Palmedo, H Guhlke, S Bender, H Sartor, J Schoeneich, G Risse, J Grunwald, F Knapp, FF Biersack, HJ
Citation: H. Palmedo et al., Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases, EUR J NUCL, 27(2), 2000, pp. 123-130
Simple new method for effective concentration of Re-188 solutions from alumina-based W-188-Re-188 generator
Authors: Guhlke, S Beets, AL Oetjen, K Mirzadeh, S Biersack, HJ Knapp, FF
Citation: S. Guhlke et al., Simple new method for effective concentration of Re-188 solutions from alumina-based W-188-Re-188 generator, J NUCL MED, 41(7), 2000, pp. 1271-1278
Risultati: 1-3 |